Aurobindo Pharma gets US FDA nod; stock gains 3%

16235 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo Pharma gets US FDA nod; stock gains 3%

Aurobindo Pharma got US FDA nod for Antibiotic Augmentin Generic, reports CNBC-TV18, quoting NewsWire18.

Post your opinion here

 

0

Tweet

Share on Tumblr

ALSO READ See latest News about Aurobindo Pharm See what other Experts & Brokerages are saying about Aurobindo Pharm See messages about Aurobindo Pharm Aurobindo Pharm BSE | NSE 30/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma got US FDA nod for Antibiotic Augmentin Generic, reports CNBC-TV18, quoting NewsWire18.

The share touched an intraday high of Rs 111 and an intraday low of Rs 107.30. At 12:16 hrs the share was quoting at Rs 110.45, up Rs 3.25, or 3.03%.
 
It was trading with volumes of 74,158 shares. In the previous trading session, the share closed down 5.05% or Rs 5.70 at Rs 107.20.

The company's trailing 12-month (TTM) EPS was at Rs 20.40 per share. (Sep, 2011). The stock's price-to-earnings (P/E) ratio was 5.42. The latest book value of the company is Rs 88.27 per share. At current value, the price-to-book value of the company was 1.25. The dividend yield of the company was 1.81%.